Healthcare providers should assess: Body composition changes (not just weight) to evaluate muscle mass preservation Glycemic control in patients with diabetes, adjusting other medications as needed Thyroid function if symptoms of hypothyroidism develop (fatigue, cold intolerance) Nutritional status through clinical assessment and laboratory testing when indicated Patients experiencing excessive fatigue, cold intolerance, or other symptoms potentially indicating metabolic suppression should be evaluated promptly, though these symptoms more commonly relate to rapid weight loss itself rather than direct drug effects
Frequently Asked Questions About GHK-Cu What is GHK-Cu used for in research
GHK-Cu, or copper tripeptide-1, is a small, skin-permeable peptide consisting of glycine, histidine, and lysine bound to copper
A daily oral weight loss treatment is more convenient than a weekly injection and likely to be a more popular choice
In this way, ADCs have a promising potential as targeted senolytic drugs to fight against age-related diseases